Marsha Comments on Drug Pricing Policy under Potential Biden Administration
Yesterday, Marsha Simon spoke to MedPage Today about how she believed Joe Biden would approach the issue of drug pricing if he wins the Presidential election. Specifically, she said that if Biden...
View ArticleCAMI Publishes Two Simon&Co Research Papers on the New UI Staffing Flexibility
The Center for Accountability, Modernization and Innovation (CAMI) has published Simon&Co. research on the early results from states that have used new, temporary flexibilities to hire contractors...
View ArticleMarsha Recognized as Top Lobbyist of 2020
The Hill has recognized Marsha Simon as one of the “Top Lobbyists of 2020.” This is the second second consecutive year Marsha has received this distinction. The full list of 2020 winners can be viewed...
View ArticleCAMI Publishes Simon&Co Analysis on SNAP Enrollment Trends
In the wake of rising of food insecurity during the pandemic, the Center for Accountability, Modernization and Innovation (CAMI) published on Dec. 15 an analysis of SNAP caseload growth due to the...
View ArticleMedPage Today Quotes Marsha Simon on ‘Most-Favored Nation’ Drug Pricing Rule
On January 7, Dr. Simon was quoted in MedPage Today for her view of the Trump Administration’s “most favored nation” rule for aligning drug prices with prices paid by other advanced industrialized...
View ArticleOf the 10 States with the Highest Share of Unemployed Workers Receiving...
In a recent New York Times article on problems with the American unemployment system, Eduardo Porter highlighted how “the system gives states incentives to scale back coverage,” resulting in most...
View Article60 Medicaid Advocates and NEMT Coalition Urge CMS to Include NEMT Within...
On March 22, Simon&Co. coordinated a letter to Acting CMS Administrator Elizabeth Richter from 60 Medicaid advocates in support of including non-emergency medical transportation (NEMT) within the...
View ArticleSimon&Co. Releases Fact Sheet on Impact of Pandemic Legislation on Postpartum...
Simon&Co. has created a fact sheet detailing how two of the pandemic relief bills – the Families First Coronavirus Response Act and the American Rescue Plan Act – have impacted Medicaid coverage...
View ArticleFact Sheet on Technology Modernization Fund Appropriations and Approved Projects
Technology-Modernization-Fund-FinalDownload
View ArticleCAMI Publishes Updated Report on the Results of UI Staffing Flexibility
The Center for Accountability, Modernization and Innovation (CAMI) has published an updated report from Simon&Co. urging the enactment of permanent staffing flexibility, at states’ option, during...
View ArticleCMS Recognizes the Right of All Medicaid Beneficiaries to NEMT
Simon&Co is pleased to note the codification of non-emergency medical transportation (NEMT) into law, thanks to a 10-year campaign by over 60 Medicaid advocates from across the country. On July...
View ArticleMedPage Today Quotes Marsha Simon on Biden Executive Order Targeting...
This week, Marsha Simon was quoted in MedPage Today for her view of President Biden’s executive order on improving competition in the prescription drug arena and other markets. “The policy does...
View ArticleNearly 60 Medicaid Advocates Urge CMS to Restore NEMT for Utah Expansion...
On October 14, Simon&Co. sent a comment letter, signed by a broad coalition of advocates for access to health care, to the Centers for Medicare and Medicaid Services (CMS) on Utah’s “Primary Care...
View ArticleNearly 60 Medicaid Advocates Urge White House and Congressional Leadership to...
On October 26, Simon&Co. coordinated a message from nearly 60 Medicaid advocacy organizations urging the White House and congressional majority leadership to retain non-emergency medical...
View ArticleInside Health Policy Quotes Marsha Simon on NEMT Coverage
Editors Amy Lotven and Maya Goldman at Inside Health Policy, a subscription-based newsletter service covering health policy news, recently quoted Marsha Simon on the push to retain the NEMT benefit in...
View ArticleMedPage Today Quotes Marsha Simon on Drug Provisions in Bipartisan...
On November 9, MedPage Today quoted Marsha Simon for her view on drug provisions of the bipartisan infrastructure bill that passed the House of Representatives last Friday. First, she commented on a...
View ArticleMarsha Simon Recognized as Top Lobbyist for Third Consecutive Year
The Hill has recognized Marsha Simon as one of the “Top Lobbyists of 2021.” This is the third consecutive year Marsha has received this distinction. The full list of 2021 winners can be viewed here.
View ArticleSenators Urge HHS Secretary Becerra to Add NEMT Option to RSNAT Model Before...
Yesterday, Inside Health Policy reported that Senators Jon Ossoff (D-GA), Raphael Warnock (D-GA), and Sherrod Brown (D-OH) are urging HHS Secretary Xavier Becerra to add NEMT for beneficiaries without...
View ArticleNearly 60 Groups Request Report Language to Delay Further Implementation of...
On February 14, Simon & Co. coordinated a letter from nearly 60 advocacy and stakeholder organizations urging House and Senate leaders to add report language to the FY22 omnibus to delay further...
View ArticleInside Health Policy Reports on Letter from Advocates Seeking to Delay RSNAT...
On March 1, 2022, Amy Lotven at Inside Health Policy reported on a Feb. 14 advocacy letter, coordinated by Simon&Co., urging House and Senate leaders to add report language to the FY22 omnibus to...
View Article